Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BDTX Black Diamond Therapeutics, Inc.	$86.1M	$0 0.0% of portfolio	0	Q4 2024 New
BPMC Blueprint Medicines Corp	$5.61B	$0 0.0% of portfolio	0	Q4 2024 New
BOLT Bolt Biotherapeutics, Inc.	$18.8M	$0 0.0% of portfolio	0	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$5.17B	$0 0.0% of portfolio	0	Q4 2024 New
CCCC C4 Therapeutics, Inc.	$156M	$0 0.0% of portfolio	0	Q4 2024 New
CABA Cabaletta Bio, Inc.	$78.6M	$0 0.0% of portfolio	0	Q4 2024 New
CANF Can Fite Bio Pharma Ltd.	$41.6M	$0 0.0% of portfolio	0	Q4 2024 New
CADL Candel Therapeutics, Inc.	$261M	$0 0.0% of portfolio	0	Q4 2024 New
CAPR Capricor Therapeutics, Inc.	$388M	$0 0.0% of portfolio	0	Q4 2024 New
CRDF Cardiff Oncology, Inc.	$186M	$0 0.0% of portfolio	0	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$82.1M	$0 0.0% of portfolio	0	Q4 2024 New
CASI Casi Pharmaceuticals, Inc.	$34M	$0 0.0% of portfolio	0	Q4 2024 New
SAVA Cassava Sciences Inc	$97M	$0 0.0% of portfolio	0	Q4 2024 Sold Out
CVM Cel Sci Corp	$18.2M	$0 0.0% of portfolio	0	Q4 2024 New
CELC Celcuity Inc.	$193M	$0 0.0% of portfolio	0	Q4 2024 New
CLDX Celldex Therapeutics, Inc.	$1.06B	$0 0.0% of portfolio	0	Q4 2024 New
CLLS Cellectis S.A.	$71.5M	$0 0.0% of portfolio	0	Q4 2024 New
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 0.0% of portfolio	0	Q4 2024 New
CNTA Centessa Pharmaceuticals PLC	$1.61B	$0 0.0% of portfolio	0	Q4 2024 New
IPSC Century Therapeutics, Inc.	$45.3M	$0 0.0% of portfolio	0	Q4 2024 New
CSBR Champions Oncology, Inc.	$150M	$0 0.0% of portfolio	0	Q4 2024 New
CMMB Chemomab Therapeutics Ltd.	$22.4M	$0 0.0% of portfolio	0	Q4 2024 New
CMRX Chimerix Inc	$384M	$0 0.0% of portfolio	0	Q4 2024 New
CDXC Chroma Dex Corp.	$401M	$0 0.0% of portfolio	0	Q4 2024 New
CINC Cin Cor Pharma, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
CLSD Clearside Biomedical, Inc.	$64.4M	$0 0.0% of portfolio	0	Q4 2024 New
CDXS Codexis, Inc.	$282M	$0 0.0% of portfolio	0	Q4 2024 New
COGT Cogent Biosciences, Inc.	$528M	$0 0.0% of portfolio	0	Q4 2024 New
CGTX Cognition Therapeutics Inc	$13.4M	$0 0.0% of portfolio	0	Q4 2024 New
CHRS Coherus Bio Sciences, Inc.	$91.7M	$0 0.0% of portfolio	0	Q4 2024 New
CLGN Coll Plant Biotechnologies LTD	$39.9M	$0 0.0% of portfolio	0	Q4 2024 New
CMPX Compass Therapeutics, Inc.	$342M	$0 0.0% of portfolio	0	Q4 2024 New
CGEN Compugen LTD	$192M	$0 0.0% of portfolio	0	Q4 2024 New
CNCE Concert Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
CNTB Connect Biopharma Holdings LTD	$50.6M	$0 0.0% of portfolio	0	Q4 2024 New
CNTX Context Therapeutics Inc.	$13.1M	$0 0.0% of portfolio	0	Q4 2024 New
CFRX Contrafect Corp	$1.18M	$0 0.0% of portfolio	0	Q4 2024 New
CRBP Corbus Pharmaceuticals Holdings, Inc.	$1.07B	$0 0.0% of portfolio	0	Q4 2024 New
CORT Corcept Therapeutics Inc	$7.79B	$0 0.0% of portfolio	0	Q4 2024 New
CRMD Cor Medix Inc.	$427M	$0 0.0% of portfolio	0	Q4 2024 New
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	0	Q4 2024 New
CRVS Corvus Pharmaceuticals, Inc.	$227M	$0 0.0% of portfolio	0	Q4 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.89B	$0 0.0% of portfolio	0	Q4 2024 New
CUE Cue Biopharma, Inc.	$52.7M	$0 0.0% of portfolio	0	Q4 2024 New
CGEM Cullinan Oncology, Inc.	$435M	$0 0.0% of portfolio	0	Q4 2024 New
CVAC Cure Vac N.V.	$684M	$0 0.0% of portfolio	0	Q4 2024 New
CYCCP Cyclacel Pharmaceuticals, Inc.	$16.5M	$0 0.0% of portfolio	-	Q4 2024 New
CYTK Cytokinetics Inc	$4.35B	$0 0.0% of portfolio	1	Q3 2023 New
CTMX Cytom X Therapeutics, Inc.	$52.8M	$0 0.0% of portfolio	0	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$901M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.